CN101838207B - 恩替卡韦的中间体及合成方法 - Google Patents
恩替卡韦的中间体及合成方法 Download PDFInfo
- Publication number
- CN101838207B CN101838207B CN2010101812893A CN201010181289A CN101838207B CN 101838207 B CN101838207 B CN 101838207B CN 2010101812893 A CN2010101812893 A CN 2010101812893A CN 201010181289 A CN201010181289 A CN 201010181289A CN 101838207 B CN101838207 B CN 101838207B
- Authority
- CN
- China
- Prior art keywords
- compound
- reagent
- reaction
- preparation
- hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC[C@@]([C@](*)CC1=N)C1=C Chemical compound CC[C@@]([C@](*)CC1=N)C1=C 0.000 description 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101812893A CN101838207B (zh) | 2006-08-24 | 2006-08-24 | 恩替卡韦的中间体及合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101812893A CN101838207B (zh) | 2006-08-24 | 2006-08-24 | 恩替卡韦的中间体及合成方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100884648A Division CN101130542B (zh) | 2006-08-24 | 2006-08-24 | 抗病毒核苷类似物的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101838207A CN101838207A (zh) | 2010-09-22 |
CN101838207B true CN101838207B (zh) | 2012-04-25 |
Family
ID=42741915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101812893A Active CN101838207B (zh) | 2006-08-24 | 2006-08-24 | 恩替卡韦的中间体及合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101838207B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104017016B (zh) * | 2013-02-28 | 2017-04-05 | 浙江星月药物科技股份有限公司 | 一类恩替卡韦的中间体的制备方法,以及中间体 |
CN108976231B (zh) * | 2018-10-26 | 2019-12-24 | 东莞理工学院 | 乙型肝炎治疗药物恩替卡韦的合成方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1747959A (zh) * | 2002-12-11 | 2006-03-15 | 布里斯托尔-迈尔斯斯奎布公司 | 制备抗病毒药[1S-( 1α, 3α, 4β)]-2-氨基-1 , 9-二氢-9-[4-羟基-3-(羟甲基)-2-亚甲环戊基]-6 H-嘌呤-6-酮的方法 |
-
2006
- 2006-08-24 CN CN2010101812893A patent/CN101838207B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1747959A (zh) * | 2002-12-11 | 2006-03-15 | 布里斯托尔-迈尔斯斯奎布公司 | 制备抗病毒药[1S-( 1α, 3α, 4β)]-2-氨基-1 , 9-二氢-9-[4-羟基-3-(羟甲基)-2-亚甲环戊基]-6 H-嘌呤-6-酮的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101838207A (zh) | 2010-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102336754B (zh) | 恩替卡韦的合成方法及其中间体化合物 | |
CN101130542B (zh) | 抗病毒核苷类似物的合成方法 | |
CN102459196A (zh) | 用于制备罗苏伐他汀的新方法,可用于制备罗苏伐他汀的中间体化合物,以及用于制备所述中间体化合物的方法 | |
JP2530848B2 (ja) | O−置換ヒドロキシルアミンの製造法 | |
CN105051031B (zh) | 1‑([1,3]二氧戊环‑4‑基甲基)‑1h‑吡唑‑3‑胺的制备方法 | |
CN101148450A (zh) | 一种核苷化合物的制备方法 | |
CN101838207B (zh) | 恩替卡韦的中间体及合成方法 | |
CN101838270B (zh) | 恩替卡韦的中间体及制备 | |
CN101863842B (zh) | 恩替卡韦中间体及合成方法 | |
CN101830856A (zh) | 恩替卡韦中间体及制备 | |
JP2003531203A (ja) | 公知のテトラゾ−ル誘導体の合成方法 | |
AU2004270465A1 (en) | Process for the preparation of renzapride and intermediates thereof | |
US20090187019A1 (en) | Process for preparing diisopropyl((1-(hydroxymethyl)-cyclopropyl)oxy)methylphosphonate | |
CN112939900B (zh) | 一种布瓦西坦中间体的制备方法 | |
CN101531660A (zh) | 一种恩替卡韦一水合物的工业化生产工艺 | |
CN102143950B (zh) | 合成取代的异喹啉的方法 | |
CN108314654B (zh) | 一种用于制备美托咪定的中间体及其制备方法和应用 | |
CN101747343B (zh) | 一种舒巴坦匹酯的制备方法 | |
EP0070013B1 (en) | Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group | |
CN115043845B (zh) | 一种西地那非的合成方法 | |
CN111320588B (zh) | 一种纯化Lesinurad的方法 | |
JPH0229672B2 (ja) | 11chikann55merukaputootetorazoorunoseizoho | |
TWI668220B (zh) | 恩替卡韋的合成方法及其中間體化合物 | |
CN100569774C (zh) | 2-氨基-6-氟-9-(4-羟基-3-羟甲基丁基)嘌呤及其中间体的制备方法 | |
CN109053847A (zh) | 一种17β-咪唑烷基溴盐-去氢表雄烷衍生物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: JIANGSU ZHENGDA TIANQING PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 222006 Sinpo City, Lianyungang Province, North Road, No. 8, No. Patentee after: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Patentee after: Borui Bio-medical Technology (Jiangsu) Co., Ltd. Address before: 222006 Sinpo City, Lianyungang Province, North Road, No. 8, No. Patentee before: Jiangsu Chiatai Tianqing Pharmaceutical Co., Ltd. Patentee before: Borui Bio-medical Technology (Jiangsu) Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: LIANYUNGANG RUIZHONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. Effective date: 20140626 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 222006 LIANYUNGANG, JIANGSU PROVINCE TO: 222069 LIANYUNGANG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140626 Address after: 222069 Golden Bridge in Jiangsu province Lianyungang City Economic and Technological Development Zone Dapu Industrial Zone, Road No. 16 Patentee after: Lianyungang Runzhong Pharmaceutical Co.,Ltd. Patentee after: Borui Bio-medical Technology (Jiangsu) Co., Ltd. Address before: 222006 Sinpo City, Lianyungang Province, North Road, No. 8, No. Patentee before: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Patentee before: Borui Bio-medical Technology (Jiangsu) Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 222069 Golden Bridge in Jiangsu province Lianyungang City Economic and Technological Development Zone Dapu Industrial Zone, Road No. 16 Patentee after: Lianyungang Runzhong Pharmaceutical Co.,Ltd. Patentee after: Borui Pharmaceutical (Suzhou) Limited by Share Ltd Address before: 222069 Golden Bridge in Jiangsu province Lianyungang City Economic and Technological Development Zone Dapu Industrial Zone, Road No. 16 Patentee before: Lianyungang Runzhong Pharmaceutical Co.,Ltd. Patentee before: Borui Bio-medical Technology (Jiangsu) Co., Ltd. |